Mitochondria comprise approximately 30% of the total intracellular volume of a mammalian cardiomyocyte. Not surprisingly, subtle alterations in mitochondrial function or membrane potential can have a dramatic influence on cardiomyocyte energy production and ultimately, the life or death individual cell. Indeed, cellular injury or stress stimulation directly elicit alterations in mitochondrial architecture, membrane potential, and oxidative capacity, which can be associated with ah irreversible loss of mitochondrial matrix contents and integral membrane protein constituents such as cytochrome C oxidase, followed soon thereafter by activation of intracellular proteases and DNA fragmentation enzymes associated with apoptosis and necrosis. An emerging paradigm places mitochondrial permeability transition pore (MPTP) formation as a central event precipitating cardiac myocyte apoptosis or necrosis following ischemic injury and during progressive heart failure. This project will test the hypothesis that MPTP is a primary mechanism responsible for driving myocardial cell death following ischemia- reperfusion injury or in response to long-standing cardiomyopathy. Both gain- and loss-of-function approaches will be implemented in the mouse as a means of dissecting the molecular determinants of MPTP and potential therapeutic opportunities.
Specific aim 1 will define the mechanism of MPTP formation and its functional consequence in regulating cardiac myocyte apoptosis.
Specific aim 2 will determine if inducible MPTP formation regulates cardiac myocyte apoptosis in vivo, while Specific aim 3 will target VDAC1/3 and cyclophilin D as a means of blocking MPTP formation in the heart. Even though inhibition of MPTP formation with pharmacologic agents often prevents cell death following catastrophic stimuli in diverse cell-types, the necessity of MPTP formation in mediating cardiomyocyte cell death following ischemic injury or long-standing cardiomyopathy has not been elucidated. Moreover, the identity and key functions of the putative MPTP components have not been subjected to genetic gain- or loss-of-function analysis in vivo, leaving the true identity of the complex unresolved. A greater understanding of the key constituents that comprise the MPTP, as well as further characterizing its functional dominance in the heart, will likely suggest novel approaches for treating human heart disease associated with cell death. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL081104-03
Application #
7262575
Study Section
Cardiac Contractility, Hypertrophy, and Failure Study Section (CCHF)
Program Officer
Liang, Isabella Y
Project Start
2005-08-01
Project End
2009-07-31
Budget Start
2007-08-01
Budget End
2008-07-31
Support Year
3
Fiscal Year
2007
Total Cost
$355,568
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Kwong, Jennifer Q; Lu, Xiyuan; Correll, Robert N et al. (2015) The Mitochondrial Calcium Uniporter Selectively Matches Metabolic Output to Acute Contractile Stress in the Heart. Cell Rep 12:15-22
Elrod, John W; Wong, Renee; Mishra, Shikha et al. (2010) Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice. J Clin Invest 120:3680-7
Wissing, Erin R; Millay, Douglas P; Vuagniaux, Grégoire et al. (2010) Debio-025 is more effective than prednisone in reducing muscular pathology in mdx mice. Neuromuscul Disord 20:753-60
Lorts, Angela; Schwanekamp, Jennifer A; Elrod, John W et al. (2009) Genetic manipulation of periostin expression in the heart does not affect myocyte content, cell cycle activity, or cardiac repair. Circ Res 104:e1-7
Baines, Christopher P; Molkentin, Jeffery D (2009) Adenine nucleotide translocase-1 induces cardiomyocyte death through upregulation of the pro-apoptotic protein Bax. J Mol Cell Cardiol 46:969-77
Molkentin, Jeffery D; Robbins, Jeffrey (2009) With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure. J Mol Cell Cardiol 46:130-6
Liu, Qinghang; Busby, Jennifer Caldwell; Molkentin, Jeffery D (2009) Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point. Nat Cell Biol 11:154-61
Maillet, Marjorie; Purcell, Nicole H; Sargent, Michelle A et al. (2008) DUSP6 (MKP3) null mice show enhanced ERK1/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibility. J Biol Chem 283:31246-55
Millay, Douglas P; Sargent, Michelle A; Osinska, Hanna et al. (2008) Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat Med 14:442-7
Houser, Steven R; Molkentin, Jeffery D (2008) Does contractile Ca2+ control calcineurin-NFAT signaling and pathological hypertrophy in cardiac myocytes? Sci Signal 1:pe31

Showing the most recent 10 out of 16 publications